Raaj Medisafe India Ltd.

As of June 30, 2026, Raaj Medisafe India Ltd. carries a market capitalization of 1.18B, placing it among publicly traded companies globally. Its enterprise value stands at 1.18B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Raaj Medisafe India Ltd. has 16.45M shares outstanding.

As of June 30, 2026, Raaj Medisafe India Ltd. trades at a trailing price-to-earnings ratio of 44.64.

As of June 30, 2026, Raaj Medisafe India Ltd. trades at an EV/EBITDA multiple of 8.91 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.26 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 10.75 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.18B versus a market cap of 1.18B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, Raaj Medisafe India Ltd. recorded 51.35M in income tax expense. That works out to an effective tax rate of 68.44, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 75.03M, leaving 23.68M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Raaj Medisafe India Ltd.'s stock has gained approximately 35.71% over the past 52 weeks. The 50-day moving average sits at 93.31, while the 200-day moving average is 84.47.

Over the twelve months ended June 30, 2026, Raaj Medisafe India Ltd. generated 936.47M in revenue and converted that into 23.68M in net income, yielding earnings per share of 1.60. EBITDA reached 131.99M, while operating income came in at 109.37M.

Over the twelve months ended June 30, 2026, Raaj Medisafe India Ltd. posted a gross margin of 34.01, reflecting its pricing power and cost economics. The operating margin of 11.68 and net profit margin of 2.53 provide insight into operational efficiency.